Clinical trial
Will Work for Reward: Effects of Ghrelin Administration on Dopamine and Effort
NCT05318924 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Will Work for Reward: Effects of Ghrelin Administration on Dopamine and Effort
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 21, 2022
- Completion date
- August 6, 2024
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.